Thus, the question remains whether the established histopathological grading criteria for malignant astrocytomas in the absence of an IDH mutation are still important if neither vascular proliferation nor necrosis are detectable. This evidence concerns the gene IDH2 and astrocytoma (excluding glioblastoma).